DE69635405D1 - Prozess zur herstellung bestimmter aza-zyklohexapeptide - Google Patents

Prozess zur herstellung bestimmter aza-zyklohexapeptide

Info

Publication number
DE69635405D1
DE69635405D1 DE69635405T DE69635405T DE69635405D1 DE 69635405 D1 DE69635405 D1 DE 69635405D1 DE 69635405 T DE69635405 T DE 69635405T DE 69635405 T DE69635405 T DE 69635405T DE 69635405 D1 DE69635405 D1 DE 69635405D1
Authority
DE
Germany
Prior art keywords
exapeptides
production
certain aza
cycle
aza cycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69635405T
Other languages
English (en)
Other versions
DE69635405T2 (de
Inventor
M Belyk
R Bender
M Black
L Hughes
William Leonard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69635405D1 publication Critical patent/DE69635405D1/de
Publication of DE69635405T2 publication Critical patent/DE69635405T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06114—Packages or dispensers for needles or sutures
    • A61B17/06133—Packages or dispensers for needles or sutures of parallelepipedal shape, e.g. made of rectangular or slightly oval panels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06114—Packages or dispensers for needles or sutures
    • A61B2017/06142—Packages or dispensers for needles or sutures having needle- or suture- retaining members, e.g. holding tabs or needle parks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dentistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69635405T 1995-02-10 1996-02-06 Prozess zur herstellung bestimmter aza-zyklohexapeptide Expired - Lifetime DE69635405T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US386619 1995-02-10
US08/386,618 US5552521A (en) 1995-02-10 1995-02-10 Process for preparing certain aza cyclohexapeptides
PCT/US1996/001523 WO1996024613A1 (en) 1995-02-10 1996-02-06 A process for preparing certain aza cyclohexapeptides

Publications (2)

Publication Number Publication Date
DE69635405D1 true DE69635405D1 (de) 2005-12-15
DE69635405T2 DE69635405T2 (de) 2006-07-27

Family

ID=23526350

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635405T Expired - Lifetime DE69635405T2 (de) 1995-02-10 1996-02-06 Prozess zur herstellung bestimmter aza-zyklohexapeptide

Country Status (21)

Country Link
US (1) US5552521A (de)
EP (1) EP0808330B1 (de)
CN (1) CN1127515C (de)
AR (2) AR001081A1 (de)
AT (1) ATE309266T1 (de)
AU (1) AU692071B2 (de)
BR (1) BR9607721A (de)
CA (1) CA2211314C (de)
CZ (2) CZ286683B6 (de)
DE (1) DE69635405T2 (de)
EA (1) EA000564B1 (de)
ES (1) ES2249778T3 (de)
FI (1) FI120693B (de)
HK (1) HK1004676A1 (de)
HR (1) HRP960054B1 (de)
HU (1) HU229780B1 (de)
NZ (1) NZ302967A (de)
SK (1) SK283115B6 (de)
TW (1) TW515805B (de)
WO (1) WO1996024613A1 (de)
YU (1) YU49459B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692043B2 (en) * 1994-08-23 1998-05-28 Merck & Co., Inc. An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
ATE223226T1 (de) * 1994-09-16 2002-09-15 Merck & Co Inc Azazyklohexapeptid-verbindungen
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
HRP970318B1 (en) * 1996-06-14 2002-06-30 Merck & Co Inc A process for preparing certain aza cyclohexapeptides
US6069126A (en) * 1996-09-12 2000-05-30 Merck & Co., Inc. Antifungal combination therapy
US5936062A (en) * 1997-06-12 1999-08-10 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
WO2000024694A1 (en) * 1998-10-28 2000-05-04 Eli Lilly And Company Photochemical process for making 1-deoxy-2-keto derivatives
AR035808A1 (es) * 2001-04-12 2004-07-14 Merck & Co Inc Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas
US7214768B2 (en) * 2002-04-08 2007-05-08 Merck & Co., Inc. Echinocandin process
EP1785432A1 (de) * 2005-11-15 2007-05-16 Sandoz AG Verfahren und Zwischenprodukte zur Synthese des Caspofungins
SI2049142T2 (sl) 2006-07-26 2016-04-29 Sandoz Ag Formulacije kaspofungina
JP5537425B2 (ja) * 2007-06-26 2014-07-02 メルク・シャープ・アンド・ドーム・コーポレーション 凍結乾燥抗真菌組成物
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
WO2009142761A1 (en) * 2008-05-21 2009-11-26 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Caspofungin bo free of caspofungin co
US8048853B2 (en) * 2008-06-13 2011-11-01 Xellia Pharmaceuticals Aps Process for preparing pharmaceutical compound and intermediates thereof
WO2010008493A2 (en) * 2008-06-25 2010-01-21 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Processes for preparing high purity aza cyclohexapeptides
KR20110011704A (ko) * 2008-06-25 2011-02-08 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 카스포펀진 불순물 ａ를 함유하지 않는 카스포펀진
WO2010064219A1 (en) 2008-12-04 2010-06-10 Ranbaxy Laboratories Limited Process for the preparation of a novel intermediate for caspofungin
EP2463293A4 (de) * 2009-08-06 2013-06-05 Shanghai Techwell Biopharm Co Azacyclohexapeptid bzw. sein pharmazeutisch akzeptables salz, herstellungsverfahren und verwendung
CN101792486A (zh) * 2010-04-12 2010-08-04 浙江海正药业股份有限公司 一种合成醋酸卡泊芬净的方法
CN102219832B (zh) 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
US9056897B2 (en) 2010-09-28 2015-06-16 DSM Sinochem Pharmaceuticals Method for isolating a cyclohexapeptide
US8927690B2 (en) * 2010-09-29 2015-01-06 Shanghai Techwell Biopharmaceutical Co., Ltd. Process for purifying cyclolipopeptide compounds or the salts thereof
CN102367267B (zh) 2010-11-10 2013-09-04 上海天伟生物制药有限公司 一种卡泊芬净的制备方法
CN102367268B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其用途
CN102367269B (zh) 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其制备方法和用途
KR101331984B1 (ko) 2010-12-09 2013-11-25 종근당바이오 주식회사 카스포펀진 제조방법 및 그의 신규 중간체
CN102219833A (zh) * 2011-04-18 2011-10-19 深圳市健元医药科技有限公司 一种更加安全的棘白菌类抗真菌药的制备方法
CN102746384B (zh) 2011-04-22 2016-01-20 上海天伟生物制药有限公司 一种高纯度的卡泊芬净或其盐及其制备方法和用途
US9321779B2 (en) 2011-04-28 2016-04-26 Unitris Biopharma Co., Ltd. Intermediate for synthesizing caspofungin and preparation method thereof
CN103483426A (zh) * 2012-06-14 2014-01-01 博瑞生物医药技术(苏州)有限公司 一种氮杂环己肽的制备方法
CA2888625A1 (en) 2012-11-20 2014-05-30 Fresenius Kabi Usa, Llc Caspofungin acetate formulations
EP3620462A1 (de) 2018-09-04 2020-03-11 Xellia Pharmaceuticals ApS Verfahren zur herstellung von caspofungin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2704030A1 (de) * 1976-02-12 1977-08-18 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
IE910892A1 (en) * 1990-03-19 1991-09-25 Merck & Co Inc Lipopeptide compounds
US5939384A (en) * 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US6268338B1 (en) * 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
AU692043B2 (en) * 1994-08-23 1998-05-28 Merck & Co., Inc. An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
ATE223226T1 (de) * 1994-09-16 2002-09-15 Merck & Co Inc Azazyklohexapeptid-verbindungen

Also Published As

Publication number Publication date
YU49459B (sh) 2006-03-03
ES2249778T3 (es) 2006-04-01
CN1127515C (zh) 2003-11-12
EA000564B1 (ru) 1999-12-29
HU229780B1 (en) 2014-07-28
CZ252597A3 (cs) 1998-01-14
US5552521A (en) 1996-09-03
SK107997A3 (en) 1998-02-04
TW515805B (en) 2003-01-01
EP0808330A1 (de) 1997-11-26
EP0808330B1 (de) 2005-11-09
DE69635405T2 (de) 2006-07-27
HRP960054B1 (en) 2008-07-31
FI120693B (fi) 2010-01-29
FI973281A0 (fi) 1997-08-08
CZ286767B6 (cs) 2000-06-14
AR001081A1 (es) 1997-09-24
EA199700170A1 (ru) 1997-12-30
CZ286683B6 (en) 2000-06-14
CA2211314A1 (en) 1996-08-15
NZ302967A (en) 1998-11-25
BR9607721A (pt) 1998-07-14
CN1173875A (zh) 1998-02-18
AR005462A1 (es) 1999-06-23
AU4914796A (en) 1996-08-27
WO1996024613A1 (en) 1996-08-15
ATE309266T1 (de) 2005-11-15
CA2211314C (en) 2007-04-17
YU8496A (sh) 1999-06-15
HUP9901085A3 (en) 2000-11-28
HUP9901085A2 (hu) 1999-09-28
HK1004676A1 (en) 1998-12-04
FI973281A (fi) 1997-08-08
HRP960054A2 (en) 1997-10-31
MX9706101A (es) 1997-10-31
AU692071B2 (en) 1998-05-28
SK283115B6 (sk) 2003-02-04

Similar Documents

Publication Publication Date Title
DE69635405D1 (de) Prozess zur herstellung bestimmter aza-zyklohexapeptide
DE69632293D1 (de) Verfahren zur Herstellung von Polysiloxan-Polycarbonat-Blockcopolymeren
DE69704964D1 (de) Verfahren zur Herstellung von Acryloxypropylsilane
DE59600015D1 (de) Verfahren zur Herstellung von Thermoplasten
DE69713022D1 (de) Verfahren zur Herstellung von Unterkleidung
DE69842201D1 (de) Verfahren zur herstellung von repliken
DE69630570D1 (de) Verfahren zur Herstellung von gestützten Membranen
DE69603810D1 (de) Verfahren zur Herstellung von Nitrilen
DE69802719D1 (de) Verfahren zur Herstellung von Acetalen
DE69508310D1 (de) Verfahren zur Herstellung von Mikrolinsen
DE59600302D1 (de) Verfahren zur Herstellung von Thermoplasten
DE59600373D1 (de) Verfahren zur Herstellung von Thermoplasten
DE69502384D1 (de) Prozess zur herstellung von polyarylenetherketonen
DE69510596D1 (de) Verfahren zur Herstellung von Organooxysilane
DE59504792D1 (de) Verfahren zur Herstellung von Serienventilen
DE59600724D1 (de) Verfahren zur Herstellung von Astaxanthin
DE69521175D1 (de) Verfahren zur Herstellung von Xanthangummi
DE59707046D1 (de) Kontinuierliches Verfahren zur Herstellung von 4-Aminopiperidinen
DE59500930D1 (de) Verfahren zur Herstellung von Ethanolaminen
DE59500545D1 (de) Verfahren zur adiabatischen Herstellung von Mononitrotoluolen
DE59600080D1 (de) Verfahren zur Herstellung von Thermoplasten
DE59603826D1 (de) Verfahren zur kontinuierlichen Herstellung von macrocyclischen Verbindungen
DE69725580D1 (de) Prozess zur herstellung von aza zyclohexapeptide
DE69613806D1 (de) Verfahren zur Herstellung von Pigmenten
DE59501267D1 (de) Verfahren zur Herstellung von Dinitrotoluol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US

R081 Change of applicant/patentee

Ref document number: 808330

Country of ref document: EP

Owner name: SCHERING CORPORATION, US

Free format text: FORMER OWNER: MERCK SHARP & DOHME CORP., 07065-0900 RAHWAY, US

Effective date: 20121213

R082 Change of representative

Ref document number: 808330

Country of ref document: EP

Representative=s name: ABITZ & PARTNER, DE

Effective date: 20121213